Cytokine Release Syndrome After Modified CAR-NK Therapy in an Advanced Non-small Cell Lung Cancer Patient: A Case Report

Use of chimeric antigen receptors (CARs), as an immune cell therapy, has generated excellent clinical outcomes against hematologic tumors in recent years. Among them, the CAR-NK (natural killer) therapy has shown better efficacy, and less toxicity, than chimeric antigen receptor T-cell (CAR-T) thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaodi, Guo, Yuying, Ji, Yinghua, Gao, Yan, Zhang, Min, Liu, Yanting, Zhu, Wuling, Lu, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073124/
https://www.ncbi.nlm.nih.gov/pubmed/35506155
http://dx.doi.org/10.1177/09636897221094244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073124/
https://www.ncbi.nlm.nih.gov/pubmed/35506155
http://dx.doi.org/10.1177/09636897221094244

Ejemplares similares